发明名称 Method for Producing Haemophilus Influenzae Type B Antigens
摘要 The invention concerns a method for producing, on an industrial scale, capsular polysaccharide of Haemophilus influenzae type b (PRP) intended for vaccine purposes, according to which a strain of Haemophilus influenzae type b (Hib) is cultured in a culture medium, the culture supernatant is harvested and treated in order to extract the capsular polysaccharide therefrom, said culture medium comprising at least: —one source of carbon, —protoporphyrin, —salts, —amino acids, —NAD or NADH, —vitamins, —means for regulating the pH, characterised in that said culture medium is chemically defined.
申请公布号 US2015167036(A1) 申请公布日期 2015.06.18
申请号 US201314411241 申请日期 2013.07.02
申请人 Sanofi Pasteur 发明人 Le Hir Jérome;Loubiere Pascal;Barbirato Fabien;Lindley Nicholas
分类号 C12P19/04;A61K39/102 主分类号 C12P19/04
代理机构 代理人
主权项 1. A process for producing, on an industrial scale, capsular polysaccharide of Haemophilus influenzae type b (PRP) suitable for use in a vaccine, the process comprising culturing a strain of Haemophilus influenzae type b (Hib) in a culture medium, and harvesting and treating the culture supernatant to extract the capsular polysaccharide therefrom, said culture medium comprising at least: a source of carbon, protoporphyrin, salts, amino acids, NAD or NADH, vitamins, pH-regulating means,wherein said culture medium is chemically defined, and comprises at least zinc.
地址 Lyon cedex 07 FR